DRUG-DRUG INTERACTIONS AS AN ISSUE IN DRUG DEVELOPMENT

被引:0
|
作者
Jochemsen, R. [1 ]
Bouzom, F. [2 ]
机构
[1] IRIS, Courbevoie, France
[2] Servier Res Grou, Orleans, France
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:2 / 2
页数:1
相关论文
共 50 条
  • [31] DRUG-DRUG INTERACTION DATABASES: SENSITIVITY AND SPECIFICITY TO DETECT MANIFEST DRUG-DRUG INTERACTIONS, RELIABILITY RATINGS AND MANAGEMENT STRATEGIES OF POTENTIAL DRUG-DRUG INTERACTIONS
    Ocovska, Z.
    Marikova, M.
    Kukralova, K.
    Vlcek, J.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S140 - S141
  • [32] Potential drug-drug interactions and admissions due to drug-drug interactions in patients treated in medical departments
    Fokter, Nina
    Mozina, Martin
    Brvar, Miran
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2010, 122 (3-4) : 81 - 88
  • [33] Potential Drug-Drug Interactions and Admissions Due to Drug-Drug Interactions in Patients Treated in Medical Departments
    Fokter, N.
    Mozina, M.
    Bone, M.
    Brvar, M.
    [J]. CLINICAL TOXICOLOGY, 2009, 47 (05) : 496 - 497
  • [34] THE REGULATORY VIEW ON DRUG-DRUG INTERACTIONS
    MULLER, HJ
    GUNDERTREMY, U
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 1994, 32 (06) : 269 - 273
  • [35] An overview of psychotropic drug-drug interactions
    Sandson, NB
    Armstrong, SC
    Cozza, KL
    [J]. PSYCHOSOMATICS, 2005, 46 (05) : 464 - 494
  • [36] Anti hypertensive drug-drug interactions
    Morales-Olivas, FJ
    Estañ, L
    [J]. MEDICINA CLINICA, 2005, 124 (20): : 782 - 789
  • [37] Drug-drug interactions are unlikely with ibandronate
    Bauss, F
    Kling, L
    Worth, E
    Barrett, J
    [J]. OSTEOPOROSIS INTERNATIONAL, 2004, 15 : S101 - S101
  • [38] Six patterns of drug-drug interactions
    Armstrong, SC
    Cozza, KL
    Sandson, NB
    [J]. PSYCHOSOMATICS, 2003, 44 (03) : 255 - 258
  • [40] Improvement in the handling of drug-drug interactions
    Fuhr, Uwe
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2008, 64 (02) : 167 - 171